BIG (participant 12) is responsible for TRANSBIG. TRANSBIG is a translational breast cancer research network supported by the European Commission, managed and represented by the Breast International Group (BIG; TRANSBIG involves 40 world-class institutions in 21 countries.

A whole-genome microarray analysis will be performed for 6000 patients. TRANSBIG aims at becoming a permanent network that would bring a coherence and synergy to translational breast cancer research that has previously not existed. It has, for example, created an independent biological materials bank facility where the fresh frozen tumor tissue, tumor paraffin blocks and blood/serum samples from the MINDACT patients will be stored.

Additional information